The correlation between amplification and overexpression and the prognostic/predictive role of overexpression of FGFR1 are less clear than those for that human epidermal growth factor 2 (HER2), which is amplified or overexpressed in a similar number of breast cancer cases [39, 40]. This evidence concerns the gene ERBB2 and breast carcinoma.